Collagen Solutions reports on a year of change with significant progress being made towards its short term goals of cash flow breakeven. The acquisition of SLB is delivering on its strategic intent. Evidence of cross selling products and services exists with sales approaching £1m. With clear evidence of meaningful gross margins (78%) and new customer wins, the anticipated higher sales volumes should begin to offset the c. £1.5m central overhead with cash flow breakeven anticipated in H2 2015/16. These margins, in turn, are expected to drive long term shareholder value.